Ozempic Lawsuit
Ozempic Lawsuit Alleges Drug Causes Blindness
The Yost Legal Group is actively investigating cases involving individuals who developed non-arteritic anterior ischemic optic neuropathy (NAION) after taking Ozempic or Wegovy. Patients who have taken Ozempic for Diabetes or weight loss and have experienced vision loss and/or blindness can file an Ozempic Lawsuit. Both Ozempic and Wagovy have been linked to NAION.
These medications are commonly prescribed for blood sugar management and weight loss. Recent reports have linked them to a serious risk: Sudden Vision Loss and Blindness. There are growing concerns regarding their potential impact on eyesight, so stay informed and take steps to protect yourself.
If you used Ozempic or Wegovy and experienced vision loss or blindness, The Yost Legal Group is here to help. For more information, call our product liability attorneys at 1-800-967-8529 or complete the form on this page, and our team will contact you shortly.
You may have a product liability claim against the drug manufacturer. Our legal team will fight for your right to seek compensation.
Ozempic & Wegovy Linked to Vision Loss: What You Need to Know
Ozempic and Wegovy are injectable medications that both use semaglutide as their active ingredient—a compound that acts like the natural hormone GLP-1 (glucagon-like peptide-1) in your body.
This hormone helps your pancreas release more insulin, which in turn lowers blood sugar levels in adults with Type 2 diabetes. Semaglutide also signals your brain to feel full sooner, making it a popular option for weight loss.
Both Ozempic and Wegovy belong to a group of drugs known as GLP-1 receptor agonists. They’re administered once a week via injection and are FDA-approved: Ozempic for managing blood sugar in Type 2 diabetes (approved in 2017), and Wegovy specifically for weight loss.
Manufactured by Novo Nordisk, these medications require a prescription from a licensed healthcare provider. Once your dose is established, you can administer the injections at home yourself.
For best results, Ozempic and Wegovy should be used in conjunction with a healthy diet and regular exercise, and they’re intended for ongoing, long-term use.
GLP-1 Medications Tied to 32% Higher Risk of NAION, JAMA Study Finds
Recent studies beginning in 2024 have linked the use of GLP-1 medications to non-arteritic anterior ischemic optic neuropathy (NAION).
The most recent findings, published in JAMA Ophthalmology in July 2025, revealed a significant association between the use of semaglutide and NAION.
In a review of medical records from over 16,000 individuals with type 2 diabetes, researchers found that those taking semaglutide had a 32% higher risk of developing NAION compared to patients not using semaglutide-based medications.
Sudden Vision Loss After Ozempic or Wegovy? Legal Help is Here
Non-arteritic anterior ischemic optic neuropathy (NAION) is a medical condition that affects the optic nerve, which is responsible for transmitting visual information from the eye to the brain.
What is NAION?
NAION stands for Non-Arteritic Anterior Ischemic Optic Neuropathy.
It is the most common cause of sudden vision loss related to the optic nerve in adults over 50.
The condition occurs when there is a sudden decrease in blood flow (ischemia) to the front part of the optic nerve (anterior), not caused by inflammation of arteries (hence, “non-arteritic”).
What Happens in NAION?
The optic nerve needs a steady blood supply to function correctly. In NAION, the small blood vessels supplying the optic nerve become blocked or narrowed, reducing oxygen and nutrients to the nerve.
This leads to sudden, painless vision loss in one eye, often noticed upon waking up.
Key Points
– Painless, sudden vision loss (usually in one eye)
– Most common in people over 50, especially those with risk factors like diabetes,
high blood pressure, or sleep apnea
– Not caused by inflammation of arteries (unlike arteritic AION, which is related to giant cell arteritis)
– Vision loss may be partial or severe and often does not fully recover
There is currently no proven treatment to reverse the vision loss, but managing risk factors can help prevent it in the other eye.
What are the Risk Factors for (NAION) Non-Arteritic Anterior Ischemic Optic Neuropathy?
– Diabetes
– High blood pressure
– High cholesterol
– Sleep apnea
– Small or crowded optic nerve head (sometimes called a “disc at risk”)
If you or someone you know experiences sudden, painless vision loss in one eye, it’s essential to consult an eye doctor or medical professional immediately to determine the cause and manage any associated risk factors.
Failure to Warn Ozempic Blindness Lawsuits
A “failure to warn” product liability lawsuit arises when a manufacturer—or any company involved in distributing a product—knew about potential dangers associated with their product but did not provide timely or sufficient warnings to the public.
This omission can result in consumers unknowingly facing risks and sustaining injuries.
In a failure to warn lawsuit based on strict liability, Plaintiffs must allege the following:
- The manufacturer knew of the danger posed by the product
- The manufacturer had a duty to warn its consumers of this product-related danger
- The manufacturer failed to warn
- The manufacturer’s failure to warn caused the plaintiff’s injury
Ozempic Lawsuits Surge Over Failure to Warn of Vision Loss Risk
The effectiveness of Ozempic in treating type II diabetes is apparent. But the increased risk of developing NAION after use is a risk that Novo failed to add to their product label.
Instead, the current warning label indicates changes in vision as a potential side effect. Manufacturers, such as Novo, have a duty to provide comprehensive warning labels on all potential risks, enabling both doctors and patients to make informed decisions before using the medication.
NAION is a serious consequence that the manufacturer has failed to warn about. As such, lawsuits have been filed against Novo by individuals who were diagnosed with NAION after using Ozempic, based on the failure to warn of this risk factor.
These lawsuits have drawn increased attention to the undisclosed health risks associated with Ozempic. It’s anticipated that this litigation will gain more momentum with time.
Call The Yost Legal Group to file your Ozempic Vision Loss Lawsuit.
If you or a loved one has been diagnosed with NAION or experienced partial or total blindness or vision loss after using Ozempic or Wegovy, you may have a claim for compensation. Our experienced product liability lawyers will assist you in filing a weight loss drug lawsuit.
Call us today at 1 (800) YOST-LAW (1-800-967-8529) or fill out the Free Consultation form on our website. We will be in touch with you shortly to conduct your free case review. It is important to know your legal options.
The defective product lawyers at The Yost Legal Group are dedicated to obtaining justice for those who have been wrongfully harmed by dangerous products, devices, and medications
Wegovy Lawsuit – Wegovy Vision Loss Lawsuit – Wegovy Blindness Lawsuit
Ozempic Claim Lawyers – Wegovy Claim Lawyers – Product Liability Attorneys
